153 related articles for article (PubMed ID: 31738620)
21. HIV-1 capsid inhibitors: a sword to destroy the virus.
Zhang X; Xu S; Sun L; Ding D; Tao Y; Kang D; Liu X; Zhan P
Future Med Chem; 2022 May; 14(9):605-607. PubMed ID: 35297282
[No Abstract] [Full Text] [Related]
22. Maturation inhibitors facilitate virus assembly and release of HIV-1 capsid P224 mutant.
Timilsina U; Ghimire D; Adhikari LP; Bhattarai A; Mishra N; Rai M; Dubey RC; Gaur R
Virology; 2018 Aug; 521():44-50. PubMed ID: 29879541
[TBL] [Abstract][Full Text] [Related]
23. Lenacapavir: a first-in-class HIV-1 capsid inhibitor.
Dvory-Sobol H; Shaik N; Callebaut C; Rhee MS
Curr Opin HIV AIDS; 2022 Jan; 17(1):15-21. PubMed ID: 34871187
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 Capsid Stabilization Assay.
Fricke T; Diaz-Griffero F
Methods Mol Biol; 2016; 1354():39-47. PubMed ID: 26714703
[TBL] [Abstract][Full Text] [Related]
25. New antiretroviral agents: looking beyond protease and reverse transcriptase.
Miller MD; Hazuda DJ
Curr Opin Microbiol; 2001 Oct; 4(5):535-9. PubMed ID: 11587929
[TBL] [Abstract][Full Text] [Related]
26. The crosstalk between antiretrovirals pharmacology and HIV drug resistance.
Giacomelli A; Pezzati L; Rusconi S
Expert Rev Clin Pharmacol; 2020 Jul; 13(7):739-760. PubMed ID: 32538221
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients.
Perrier M; Bertine M; Le Hingrat Q; Joly V; Visseaux B; Collin G; Landman R; Yazdanpanah Y; Descamps D; Charpentier C
J Antimicrob Chemother; 2017 Oct; 72(10):2954-2955. PubMed ID: 29091184
[No Abstract] [Full Text] [Related]
28. Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer.
Xu JP; Branson JD; Lawrence R; Cocklin S
Bioorg Med Chem Lett; 2016 Feb; 26(3):824-828. PubMed ID: 26747394
[TBL] [Abstract][Full Text] [Related]
29. Dendrimers as potential inhibitors of the dimerization of the capsid protein of HIV-1.
Doménech R; Abian O; Bocanegra R; Correa J; Sousa-Herves A; Riguera R; Mateu MG; Fernandez-Megia E; Velázquez-Campoy A; Neira JL
Biomacromolecules; 2010 Aug; 11(8):2069-78. PubMed ID: 20690715
[TBL] [Abstract][Full Text] [Related]
30. Inhibitors of the HIV-1 capsid, a target of opportunity.
Carnes SK; Sheehan JH; Aiken C
Curr Opin HIV AIDS; 2018 Jul; 13(4):359-365. PubMed ID: 29782334
[TBL] [Abstract][Full Text] [Related]
31. Benzamide-based thiolcarbamates: a new class of HIV-1 NCp7 inhibitors.
Goel A; Mazur SJ; Fattah RJ; Hartman TL; Turpin JA; Huang M; Rice WG; Appella E; Inman JK
Bioorg Med Chem Lett; 2002 Mar; 12(5):767-70. PubMed ID: 11858998
[TBL] [Abstract][Full Text] [Related]
32. Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: addressing configurational instability through scaffold modification.
Fader LD; Landry S; Morin S; Kawai SH; Bousquet Y; Hucke O; Goudreau N; Lemke CT; Bonneau P; Titolo S; Mason S; Simoneau B
Bioorg Med Chem Lett; 2013 Jun; 23(11):3396-400. PubMed ID: 23583513
[TBL] [Abstract][Full Text] [Related]
33. Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography.
Goudreau N; Lemke CT; Faucher AM; Grand-Maître C; Goulet S; Lacoste JE; Rancourt J; Malenfant E; Mercier JF; Titolo S; Mason SW
ACS Chem Biol; 2013 May; 8(5):1074-82. PubMed ID: 23496828
[TBL] [Abstract][Full Text] [Related]
34. Pharmacologic hyperstabilisation of the HIV-1 capsid lattice induces capsid failure.
Faysal KMR; Walsh JC; Renner N; Márquez CL; Shah VB; Tuckwell AJ; Christie MP; Parker MW; Turville SG; Towers GJ; James LC; Jacques DA; Böcking T
Elife; 2024 Feb; 13():. PubMed ID: 38347802
[TBL] [Abstract][Full Text] [Related]
35. Targeting the Early Step of Building Block Organization in Viral Capsid Assembly.
Lampel A; Bram Y; Ezer A; Shaltiel-Kario R; Saad JS; Bacharach E; Gazit E
ACS Chem Biol; 2015 Aug; 10(8):1785-90. PubMed ID: 25997366
[TBL] [Abstract][Full Text] [Related]
36. Antiretroviral therapy. Sequencing antiretrovirals.
MacArthur RD
AIDS Read; 2000 Jun; 10(6):359-64. PubMed ID: 10881367
[TBL] [Abstract][Full Text] [Related]
37. The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly.
Neira JL
FEBS J; 2009 Nov; 276(21):6110-7. PubMed ID: 19825045
[TBL] [Abstract][Full Text] [Related]
38. Monitoring the emergence of antiretroviral resistance.
Wkly Epidemiol Rec; 2001 Jun; 76(25):195-6. PubMed ID: 11436488
[No Abstract] [Full Text] [Related]
39. Accumulation of MxB/Mx2-resistant HIV-1 Capsid Variants During Expansion of the HIV-1 Epidemic in Human Populations.
Wei W; Guo H; Ma M; Markham R; Yu XF
EBioMedicine; 2016 Jun; 8():230-236. PubMed ID: 27428433
[TBL] [Abstract][Full Text] [Related]
40. Antiretroviral resistance.
Geretti AM
J HIV Ther; 2006 Dec; 11(4):72-3. PubMed ID: 17578209
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
